Bill

Bill > HF2476


MN HF2476

MN HF2476
Over-the-counter allergy medicine sale restrictions modified.


summary

Introduced
03/17/2025
In Committee
03/17/2025
Crossed Over
Passed
Dead

Introduced Session

94th Legislature 2025-2026

Bill Summary

A bill for an act relating to controlled substances; modifying restrictions placed on the sale of certain over-the-counter allergy medicines; amending Minnesota Statutes 2024, section 152.02, subdivision 6.

AI Summary

This bill modifies restrictions on the sale of over-the-counter allergy medicines containing ephedrine or pseudoephedrine (methamphetamine precursor drugs) in Minnesota. The key changes include adjusting the maximum purchase limit from 6 to 7.2 grams within a 30-day period and modifying the package size limit to 3.6 grams per package. The bill maintains strict regulations requiring these medications to be displayed behind checkout counters and sold only by licensed pharmacy personnel. Buyers must provide photo ID and sign a document detailing their purchase, which the store must keep for at least three years. The bill continues to prohibit sales to individuals under 18 and maintains criminal penalties for violations, including potential fines up to $1,000 and/or 90 days imprisonment. The legislation provides some exemptions, such as for pediatric products and certain formulations that are less likely to be used in methamphetamine production. Importantly, the bill preempts local ordinances regulating the sale of these medications, effectively creating a statewide standard for their sale and distribution.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Introduction and first reading, referred to Health Finance and Policy (on 03/17/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...